Nan Wang
76 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Therapeutic mechanism of imperatorin in allergic rhinitis via anti-inflammatory action and restoration of nasal epithelial barrier integrity.
Journal: Toxicology and applied pharmacology
Published: December 30, 2025
Correction: TPP-coated Mo-doped W18O49 biodegradable nanomaterials with mitochondria-targeting and pH-responsive properties for synergistic photothermal therapy/chemodynamic therapy/chemotherapy.
Journal: Biomaterials science
Published: November 17, 2025
TPP-coated Mo-doped W18O49 biodegradable nanomaterials with mitochondria-targeting and pH-responsive properties for synergistic photothermal therapy/chemodynamic therapy/chemotherapy.
Journal: Biomaterials science
Published: September 29, 2025
CaV1.2 Is Implicated in IgE-Mediated Mast Cell Activation and Food Allergy.
Journal: Clinical and experimental pharmacology & physiology
Published: September 17, 2025
Efficient screening and evaluation of MRGPRX2 antagonists based on AlphaFold 3.
Journal: Biochemical pharmacology
Published: August 15, 2025
Screening Potential Anti-Respiratory Syncytial Virus Substances From Forsythia suspensa Using a High-Expressing Fusion Protein Cell Membrane Chromatography.
Journal: Journal of separation science
Published: July 03, 2025
Clarithromycin attenuates severe steroid hyporesponsive asthma by regulating type 2/type 17 inflammation balance and inhibiting mast cell activation.
Journal: Toxicology and applied pharmacology
Published: May 21, 2025
Development and validation of an ADRβ1-SNAP-tag/CMC model for screening ADRβ1 antagonists: Application to nebivolol and its byproducts.
Journal: Journal of pharmaceutical and biomedical analysis
Published: April 21, 2025
"Relative symmetry with electronegativity of different key-groups" strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation.
Journal: Acta pharmaceutica Sinica. B
Published: October 28, 2024
Zyxin-a novel detrimental target, is inhibited by Saikosaponin A during allergic asthma.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 20, 2024
Depression of CaV1.2 activation and expression in mast cells ameliorates allergic inflammation diseases.
Journal: Journal of pharmaceutical analysis
Published: August 15, 2024
Last Updated: 09/26/2026